(secondQuint)A Safety and Efficacy Study to Evaluate AMG 785 in South Korean Women With Osteoporosis.

.

 This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study in women with osteoporosis.

 The study is designed to evaluate if treatment with Romosozumab (AMG 785) once a month for 6 months compared with placebo is effective in increasing bone mineral density.

.

 A Safety and Efficacy Study to Evaluate AMG 785 in South Korean Women With Osteoporosis.

@highlight

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the effect of 6 months treatment with Romosozumab compared to placebo by determining the percent changes in bone mineral density